Genesis DNA
2015
FOUNDED
OOB
STATUS
1-10
EMPLOYEES
Out of Business
LATEST DEAL TYPE
Description
Developer of a genome technology intended to make gene synthesis rapid, inexpensive, and sequence invariant. The company develops a technology that helps to convert digital text into physical DNA, thereby circumventing the cost, turnaround time, and sequence limiting factors of existing synthesis methods.
Primary Industry
Biotechnology
Primary Office
- Cambridge, MA
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Genesis DNA’s full profile, request a free trial.
Genesis DNA Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-May-2017 | 00000 | Completed | Out of Business | ||
| 4. Early Stage VC | 00000 | Completed | Startup | |||
| 3. Accelerator/Incubator | 01-Jan-2016 | 00000 | Completed | Startup | ||
| 2. Accelerator/Incubator | 12-Sep-2015 | $20K | $250K | Completed | Startup | |
| 1. Accelerator/Incubator | 10-Sep-2015 | $250K | $250K | 00.000 | Completed | Startup |